Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Real-World Data on the Use of rFIXFc in Subjects With Hemophilia B for Up to 3.7 Years Demonstrates Improved Bleed Control and Adherence With Reduced Treatment Burden

Amy Shapiro, Ateefa Chaudhury, Nisha Jain, Elisa Tsao, Chris Barnowski, Jing Feng, Doris Quon

Blood (2018) 132 (Supplement 1): 2493.

https://doi.org/10.1182/blood-2018-99-116909

Published: 2018

Journal Articles

Validation of the Khorana Score in a Large Cohort of Cancer Patients with Venous Thromboembolism

Ateefa Chaudhury, MD, Asha Balakrishnan, MD, Christy Thai, PharmD, BCPS, Bjorn Holmstrom, MD, Sowmya Nanjappa, MD, Zhenjun Ma, PhD, Junmin Zhou, PhD, Ankita Patel, MD, Nathan Visweshwar, MD, Michael V. Jaglal, MD

Blood (2016) 128 (22): 879.

https://doi.org/10.1182/blood.V128.22.879.879

Published: 2016

Journal Articles

Evaluation of Rivaroxaban and Dalteparin in Cancer Associated Thrombosis

Ateefa Chaudhury, MD, Asha Balakrishnan, MD, Christy Thai, PharmD, BCPS, Bjorn Holmstrom, MD, Michael V. Jaglal, MD

Blood (2015) 126 (23): 432.

https://doi.org/10.1182/blood.V126.23.432.432

Published: 2015

Journal Articles

Prognosis and Outcomes in MDS-MPN Unclassifiable: Single Institution Experience of a Rare Disorder

Ateefa Chaudhury, MD, Rami S. Komrokji, MD, Najla H. Al Ali, BDS, MSc, Ling Zhang, MD, Pardis Vafaii, MD, Jeffrey E. Lancet, MD

Blood (2015) 126 (23): 1698.

https://doi.org/10.1182/blood.V126.23.1698.1698

Published: 2015

Journal Articles

Utilization of Targeted Exome Sequencing to Determine Implications of TP53 Mutation Status in Relation to 17p Deletion in Chronic Lymphocytic Leukemia (CLL)

Ateefa Chaudhury, MD, Julio C Chavez, MD, Javier Pinilla-Ibarz, MD PhD

Blood (2014) 124 (21): 3287.

https://doi.org/10.1182/blood.V124.21.3287.3287

Published: 2014

NARROW

Real-World Data on the Use of rFIXFc in Subjects With Hemophilia B for Up to 3.7 Years Demonstrates Improved Bleed Control and Adherence With Reduced Treatment Burden

Validation of the Khorana Score in a Large Cohort of Cancer Patients with Venous Thromboembolism

Evaluation of Rivaroxaban and Dalteparin in Cancer Associated Thrombosis

Prognosis and Outcomes in MDS-MPN Unclassifiable: Single Institution Experience of a Rare Disorder

Utilization of Targeted Exome Sequencing to Determine Implications of TP53 Mutation Status in Relation to 17p Deletion in Chronic Lymphocytic Leukemia (CLL)

Email alerts

ASH Publications

American Society of Hematology

Real-World Data on the Use of rFIXFc in Subjects With Hemophilia B for Up to 3.7 Years Demonstrates Improved Bleed Control and Adherence With Reduced Treatment Burden

Validation of the Khorana Score in a Large Cohort of Cancer Patients with Venous Thromboembolism

Evaluation of Rivaroxaban and Dalteparin in Cancer Associated Thrombosis

Prognosis and Outcomes in MDS-MPN Unclassifiable: Single Institution Experience of a Rare Disorder

Utilization of Targeted Exome Sequencing to Determine Implications of TP53 Mutation Status in Relation to 17p Deletion in Chronic Lymphocytic Leukemia (CLL)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only